• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪分解与脂肪生成之间的微妙平衡:代谢稳态的关键点。

The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.

作者信息

Saponaro Chiara, Gaggini Melania, Carli Fabrizia, Gastaldelli Amalia

机构信息

Cardiometabolic Risk Unit, Institute of Clinical Physiology, CNR, via Moruzzi, 1 56124 Pisa, Italy.

Dipartimento di Biotecnologie, Chimica e Farmacia, Università di Siena, 53100 Siena, Italy.

出版信息

Nutrients. 2015 Nov 13;7(11):9453-74. doi: 10.3390/nu7115475.

DOI:10.3390/nu7115475
PMID:26580649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4663603/
Abstract

Excessive accumulation of lipids can lead to lipotoxicity, cell dysfunction and alteration in metabolic pathways, both in adipose tissue and peripheral organs, like liver, heart, pancreas and muscle. This is now a recognized risk factor for the development of metabolic disorders, such as obesity, diabetes, fatty liver disease (NAFLD), cardiovascular diseases (CVD) and hepatocellular carcinoma (HCC). The causes for lipotoxicity are not only a high fat diet but also excessive lipolysis, adipogenesis and adipose tissue insulin resistance. The aims of this review are to investigate the subtle balances that underlie lipolytic, lipogenic and oxidative pathways, to evaluate critical points and the complexities of these processes and to better understand which are the metabolic derangements resulting from their imbalance, such as type 2 diabetes and non alcoholic fatty liver disease.

摘要

脂质的过度积累会导致脂毒性、细胞功能障碍以及脂肪组织和外周器官(如肝脏、心脏、胰腺和肌肉)代谢途径的改变。现在,这是肥胖、糖尿病、脂肪性肝病(NAFLD)、心血管疾病(CVD)和肝细胞癌(HCC)等代谢紊乱发展的一个公认风险因素。脂毒性的原因不仅是高脂肪饮食,还包括过度的脂肪分解、脂肪生成和脂肪组织胰岛素抵抗。本综述的目的是研究脂解、脂肪生成和氧化途径背后的微妙平衡,评估这些过程的关键点和复杂性,并更好地理解由它们的失衡导致的代谢紊乱,如2型糖尿病和非酒精性脂肪性肝病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/ad7197bf9424/nutrients-07-05475-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/be417730d51b/nutrients-07-05475-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/1df2b74ea3ac/nutrients-07-05475-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/05da327c050a/nutrients-07-05475-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/50252580e758/nutrients-07-05475-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/9e950f86a5c4/nutrients-07-05475-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/ad7197bf9424/nutrients-07-05475-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/be417730d51b/nutrients-07-05475-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/1df2b74ea3ac/nutrients-07-05475-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/05da327c050a/nutrients-07-05475-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/50252580e758/nutrients-07-05475-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/9e950f86a5c4/nutrients-07-05475-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8257/4663603/ad7197bf9424/nutrients-07-05475-g006.jpg

相似文献

1
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.脂肪分解与脂肪生成之间的微妙平衡:代谢稳态的关键点。
Nutrients. 2015 Nov 13;7(11):9453-74. doi: 10.3390/nu7115475.
2
Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.肝脏脂质蓄积:血糖调节激素失调的原因及后果
J Endocrinol. 2017 Jul;234(1):R1-R21. doi: 10.1530/JOE-16-0513. Epub 2017 Apr 20.
3
Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.非酒精性脂肪性肝病与2型糖尿病:共同的病理生理机制
Curr Diab Rep. 2015 Jun;15(6):607. doi: 10.1007/s11892-015-0607-4.
4
Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction.非酒精性脂肪性肝病的病理生理学:生活方式-肠道-基因相互作用
Dig Dis. 2016;34 Suppl 1:3-10. doi: 10.1159/000447275. Epub 2016 Aug 22.
5
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.肥胖和脂毒性在非酒精性脂肪性肝炎发展中的作用:病理生理学和临床意义。
Gastroenterology. 2012 Apr;142(4):711-725.e6. doi: 10.1053/j.gastro.2012.02.003. Epub 2012 Feb 8.
6
Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice.托格列净可改善雄性小鼠骨骼肌中的胰岛素抵抗并加速脂肪组织中的脂肪分解。
Endocrinology. 2016 Mar;157(3):1029-42. doi: 10.1210/en.2015-1588. Epub 2015 Dec 29.
7
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.非酒精性脂肪性肝病、代谢风险因素与肝细胞癌:一个悬而未决的问题。
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
8
Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.胰岛素抵抗和脂毒性在非酒精性脂肪性肝炎中的作用。
Clin Liver Dis. 2009 Nov;13(4):545-63. doi: 10.1016/j.cld.2009.07.009.
9
NAFLD and diabetes mellitus.非酒精性脂肪性肝病和糖尿病。
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):32-42. doi: 10.1038/nrgastro.2016.147. Epub 2016 Oct 12.
10
Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.异位脂肪、胰岛素抵抗与非酒精性脂肪性肝病。
Proc Nutr Soc. 2013 Nov;72(4):412-9. doi: 10.1017/S0029665113001249. Epub 2013 May 14.

引用本文的文献

1
Diabetic Ketoacidosis Is Associated with Lower Serum Sphingolipids but Higher β-Hydroxybutyrate and Lactate: A Pilot Study.糖尿病酮症酸中毒与较低的血清鞘脂相关,但与较高的β-羟基丁酸和乳酸相关:一项初步研究。
Pathophysiology. 2025 Jun 26;32(3):29. doi: 10.3390/pathophysiology32030029.
2
Hesperidin Is a Promising Nutraceutical Compound in Counteracting the Progression of NAFLD In Vitro.橙皮苷是一种有前景的营养保健品化合物,可在体外对抗非酒精性脂肪性肝病的进展。
Int J Mol Sci. 2025 Jun 21;26(13):5982. doi: 10.3390/ijms26135982.
3
High carbohydrate diet programs metabolic enzyme gene expression modification in F2 generation wistar rat males.

本文引用的文献

1
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.胰高血糖素样肽1可降低非酒精性脂肪性肝炎中的脂毒性。
J Hepatol. 2016 Feb;64(2):399-408. doi: 10.1016/j.jhep.2015.08.038. Epub 2015 Sep 21.
2
Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.神经酰胺作为非酒精性脂肪性肝病及相关动脉粥样硬化的介质。
PLoS One. 2015 May 20;10(5):e0126910. doi: 10.1371/journal.pone.0126910. eCollection 2015.
3
Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases.
高碳水化合物饮食会改变F2代雄性Wistar大鼠的代谢酶基因表达。
Curr Res Physiol. 2025 Jun 18;8:100154. doi: 10.1016/j.crphys.2025.100154. eCollection 2025.
4
Animal-Free Setup of a 3D Mature Adipocyte-Macrophage Co-Culture to Induce Inflammation In Vitro.用于体外诱导炎症的3D成熟脂肪细胞-巨噬细胞共培养的无动物实验设置
Adv Healthc Mater. 2025 Aug;14(22):e2500779. doi: 10.1002/adhm.202500779. Epub 2025 Jun 20.
5
Association between eGDR and MASLD and liver fibrosis: a cross-sectional study based on NHANES 2017-2023.估算肾小球滤过率与代谢相关脂肪性肝病及肝纤维化之间的关联:一项基于2017 - 2023年美国国家健康与营养检查调查的横断面研究。
Front Med (Lausanne). 2025 May 30;12:1579879. doi: 10.3389/fmed.2025.1579879. eCollection 2025.
6
Differential Effects of Wild Blueberry (Poly)Phenol Metabolites in Modulating Lipid Metabolism and Oxidative Stress in 3T3-L1 Adipocytes.野生蓝莓(多)酚代谢物对3T3-L1脂肪细胞脂质代谢和氧化应激的差异影响。
Mol Nutr Food Res. 2025 Aug;69(15):e70101. doi: 10.1002/mnfr.70101. Epub 2025 May 9.
7
Nonalcoholic fatty liver disease following laparoscopic duodenum-preserving pancreatic total head resection laparoscopic pancreaticoduodenectomy: A retrospective cohort study.腹腔镜保留十二指肠胰头全切除术(腹腔镜胰十二指肠切除术)后非酒精性脂肪性肝病:一项回顾性队列研究
World J Gastroenterol. 2025 Apr 7;31(13):104046. doi: 10.3748/wjg.v31.i13.104046.
8
Small Extracellular Vesicle-Derived Nicotinamide Phosphoribosyltransferase (NAMPT) Induces Acyl-Coenzyme A Synthetase SLC27A4-Mediated Glycolysis to Promote Hepatocellular Carcinoma.小细胞外囊泡衍生的烟酰胺磷酸核糖基转移酶(NAMPT)诱导酰基辅酶A合成酶SLC27A4介导的糖酵解以促进肝细胞癌。
J Extracell Vesicles. 2025 Apr;14(4):e70071. doi: 10.1002/jev2.70071.
9
Visceral adiposity index, premature mortality, and life expectancy in US adults.美国成年人的内脏脂肪指数、过早死亡率和预期寿命
Lipids Health Dis. 2025 Apr 15;24(1):139. doi: 10.1186/s12944-025-02560-3.
10
Frequency of insulin resistance among non-diabetic patients with non-alcoholic fatty liver disease using HOMA-IR: an experience of a tertiary care hospital in Karachi, Pakistan.使用稳态模型评估胰岛素抵抗指数(HOMA-IR)评估非酒精性脂肪性肝病非糖尿病患者的胰岛素抵抗频率:巴基斯坦卡拉奇一家三级医院的经验
BMC Gastroenterol. 2025 Apr 15;25(1):259. doi: 10.1186/s12876-025-03790-6.
并非所有脂肪都是一样的:脂肪组织与异位脂肪,对心血管代谢疾病的影响
Horm Mol Biol Clin Investig. 2015 Apr;22(1):7-18. doi: 10.1515/hmbci-2015-0006.
4
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.肝细胞癌从诊断到死亡的全球管理模式:BRIDGE研究
Liver Int. 2015 Sep;35(9):2155-66. doi: 10.1111/liv.12818. Epub 2015 Mar 25.
5
Metabolically normal obese people are protected from adverse effects following weight gain.代谢正常的肥胖人群在体重增加后能免受不良影响。
J Clin Invest. 2015 Feb;125(2):787-95. doi: 10.1172/JCI78425. Epub 2015 Jan 2.
6
Free fatty acids shift insulin-induced hepatocyte proliferation towards CD95-dependent apoptosis.游离脂肪酸将胰岛素诱导的肝细胞增殖转变为CD95依赖性凋亡。
J Biol Chem. 2015 Feb 13;290(7):4398-409. doi: 10.1074/jbc.M114.617035. Epub 2014 Dec 29.
7
Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.从头脂肪生成途径中的脂肪酸与2型糖尿病风险的前瞻性关联:心血管健康研究
Am J Clin Nutr. 2015 Jan;101(1):153-63. doi: 10.3945/ajcn.114.092601. Epub 2014 Nov 12.
8
Leptin resistance and diet-induced obesity: central and peripheral actions of leptin.瘦素抵抗和饮食诱导的肥胖:瘦素的中枢和外周作用。
Metabolism. 2015 Jan;64(1):35-46. doi: 10.1016/j.metabol.2014.10.015. Epub 2014 Oct 23.
9
Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.非酒精性脂肪性肝病中的肝细胞癌:环境与遗传因素的作用
World J Gastroenterol. 2014 Sep 28;20(36):12945-55. doi: 10.3748/wjg.v20.i36.12945.
10
Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients.脂肪细胞大小、游离脂肪酸和载脂蛋白与重度肥胖患者非酒精性肝损伤进展相关。
Metabolism. 2014 Dec;63(12):1542-52. doi: 10.1016/j.metabol.2014.09.001. Epub 2014 Sep 6.